Executive Summary........ 1
Introduction........ .4
The Rise of the Environmental Movement ........ 10
Evolution of the FDA........... 11
Silent Spring........... 13
Birth of the EPA........... 16
Environmental Risk........ 19
Carcinogenic Risk ........... 21
Non-Carcinogenic Risk ........... 24
Endocrine Disruptors........... 25
Green Chemicals—Natural v. Synthetic........... ...................28
Politics of the Precautionary Principle........ 33
Environmental NGOs and the ........... 37
Reforming the Toxic Substances Control Act........... 39
President’s Cancer Panel Annual Report for 2008-2009 ........... 42
Case Study: Bisphenol A—Precautionary Regulation ........ 44
Campaigns Against BPA........... 45
Low Dose Theory ........... 48
Ideological Regulation........... 52
FDA and EPA Weigh In. ........... 55
Case Study: Atrazine—Weighing Risks and Benefits ........ 58
Studies and Regulation ........... 60
Harm Versus Risk ........... 63
The “Endocrine Disruptor” Hypothesis Controversy ........... 66
A Precautionary Future?........... 72
Implications for Public Health ........ 73
Benefits of a Chemical Exceed Risks ........... 73
Risks of Replacement or Amelioration Exceed Benefits. ........... 75
Psychology of Risk Perception ........... 77
Trust in Scientists and Science ........... 79
Appendix: Common Myths and Facts About Chemicals........ 83
Bibliography ........ 93